glp-1 mcas Could Medications Be a Game-Changer for MCAS? Signaling Pathways of the GLP-1

Chonnam Med

Clinical trials are being run on combination therapies that can help preserve muscle massa big issue for GLP-1 usersand maybe even cut back on GI symptoms

rather, they promote generalised weight loss through reduced energy intake and metabolic changes

Advantages: - Once-weekly convenience for most formulas - Well-studied efficacy and safety data - More consistent absorption - Compounded versions available at lower cost Considerations: - Requires self-injection or provider administration - Needles can be a barrier for some patients Oral semaglutide (Rybelsus) is currently the only FDA-approved oral GLP-1 medication